Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elmer Maurits

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
EMBO Reports|October 4, 2018
Co-inhibition of immunoproteasome subunits LMP2 and LMP7 is required to block autoimmunityMichael Basler, Michelle M Lindstrom, Jacob J LaStant, et al.
Journal of the American Chemical Society|April 11, 2020
Immunoproteasome Inhibitor-Doxorubicin Conjugates Target Multiple Myeloma Cells and Release Doxorubicin upon Low-Dose Photon IrradiationElmer Maurits, Michel J van de Graaff, Santina Maiorana, et al.
Chemical Science|September 9, 2024
Selective labelling of GBA2 in cells with fluorescent β-d-arabinofuranosyl cyclitol aziridinesQin Su, Max Louwerse, Rob F Lammers, et al.
Antimicrobial Agents and Chemotherapy|November 11, 2025
Inhibitors of the 20S proteasome β5 subunit as potent and selective agents against <i>Trichomonas vaginalis</i>Yukiko Miyamoto, Brianna M Hurysz, Pavla Fajtova, et al.
Journal of Medicinal Chemistry|January 19, 2019
Structure-Based Design of Inhibitors Selective for Human Proteasome β2c or β2i SubunitsBo-Tao Xin, Eva M Huber, Gerjan de Bruin, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 11, 2020
Fluorogenic Bifunctional trans-Cyclooctenes as Efficient Tools for Investigating Click-to-Release KineticsMark A R de Geus, Elmer Maurits, Alexi J C Sarris, et al.
Haematologica|February 2, 2023
High-dose carfilzomib achieves superior anti-tumor activity over low-dose and recaptures response in relapsed/refractory multiple myeloma resistant to lowdose carfilzomib by co-inhibiting the β2 and β1 subunits of the proteasome complexXiang Zhou, Andrej Besse, Jessica Peter, et al.
ACS Chemical Biology|May 8, 2018
Chemical Control over T-Cell Activation in Vivo Using Deprotection of trans-Cyclooctene-Modified EpitopesAnouk M F van der Gracht, Mark A R de Geus, Marcel G M Camps, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
EMBO Reports|October 4, 2018
Co-inhibition of immunoproteasome subunits LMP2 and LMP7 is required to block autoimmunityMichael Basler, Michelle M Lindstrom, Jacob J LaStant, et al.
Journal of the American Chemical Society|April 11, 2020
Immunoproteasome Inhibitor-Doxorubicin Conjugates Target Multiple Myeloma Cells and Release Doxorubicin upon Low-Dose Photon IrradiationElmer Maurits, Michel J van de Graaff, Santina Maiorana, et al.
Chemical Science|September 9, 2024
Selective labelling of GBA2 in cells with fluorescent β-d-arabinofuranosyl cyclitol aziridinesQin Su, Max Louwerse, Rob F Lammers, et al.
Antimicrobial Agents and Chemotherapy|November 11, 2025
Inhibitors of the 20S proteasome β5 subunit as potent and selective agents against <i>Trichomonas vaginalis</i>Yukiko Miyamoto, Brianna M Hurysz, Pavla Fajtova, et al.
Journal of Medicinal Chemistry|January 19, 2019
Structure-Based Design of Inhibitors Selective for Human Proteasome β2c or β2i SubunitsBo-Tao Xin, Eva M Huber, Gerjan de Bruin, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 11, 2020
Fluorogenic Bifunctional trans-Cyclooctenes as Efficient Tools for Investigating Click-to-Release KineticsMark A R de Geus, Elmer Maurits, Alexi J C Sarris, et al.
Haematologica|February 2, 2023
High-dose carfilzomib achieves superior anti-tumor activity over low-dose and recaptures response in relapsed/refractory multiple myeloma resistant to lowdose carfilzomib by co-inhibiting the β2 and β1 subunits of the proteasome complexXiang Zhou, Andrej Besse, Jessica Peter, et al.
ACS Chemical Biology|May 8, 2018
Chemical Control over T-Cell Activation in Vivo Using Deprotection of trans-Cyclooctene-Modified EpitopesAnouk M F van der Gracht, Mark A R de Geus, Marcel G M Camps, et al.
Pageof 2